SCM
SRNE

Suvretta Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Suvretta Capital Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-105,744
Closed -$492K – 110
2021
Q4 		$492K Buy
+105,744
New +$492K 0.01% 89